Milton H. Werner
Net Worth

Last updated:

What is Milton H. Werner net worth?

The estimated net worth of Dr. Milton H. Werner is at least $10,459,659 as of 16 Aug 2022. He owns shares worth $9,230,299 as insider and has received compensation worth at least $1,229,360 in Inhibikase Therapeutics, Inc..

What is the salary of Milton H. Werner?

Dr. Milton H. Werner salary is $307,340 per year as Chief Executive Officer, Pres & Director in Inhibikase Therapeutics, Inc..

How old is Milton H. Werner?

Dr. Milton H. Werner is 62 years old, born in 1963.

What stocks does Milton H. Werner currently own?

As insider, Dr. Milton H. Werner owns shares in one company:

Company Title Shares Price per share Total value
Inhibikase Therapeutics, Inc. (IKT) Chief Executive Officer, Pres & Director 5,335,433 $1.73 $9,230,299

What does Inhibikase Therapeutics, Inc. do?

Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.

IKT logo
IKT
Inhibikase Therapeutics, Inc.
$1.73

Milton H. Werner insider trading

Inhibikase Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $0.8 $4,000
Purchase
Common Stock 5,000 $0.98 $4,880
Purchase
Common Stock 10,000 $0.6 $6,000
Option
Common Stock 21,853 $2.02 $44,143
Option
Stock Option (right to buy) 21,853 $2.02 $44,143
Purchase
Common Stock 400 $1.93 $772
Option
Common Stock 21,853 $2.02 $44,143
Option
Stock Option (right to buy) 21,853 $2.02 $44,143
Option
Stock Option (right to buy) 43,707 N/A N/A
Option
Common Stock 43,707 N/A N/A

Inhibikase Therapeutics key executives

Inhibikase Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Dr. Milton H. Werner (62) Chief Executive Officer, Pres & Director
  • Mr. Joseph Frattaroli CPA (63) Chief Financial Officer